Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Webcast ImageWebcast
Q2 2019 Charles River Laboratories International, Inc. Earnings Conference Call (Live)
07/31/19 at 8:30 a.m. ET

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


News Releases

DateTitle 
07/16/19Charles River Laboratories Schedules Second-Quarter 2019 Earnings Release and Conference CallPrinter Friendly Version
07/09/19Charles River Laboratories to Open Flexible Vivarium Space for Clients in South San FranciscoPrinter Friendly Version
06/03/19Charles River Laboratories to Present at Jefferies and Goldman Sachs Investor ConferencesPrinter Friendly Version
05/16/19Charles River Laboratories Invests in Resero Analytics™Printer Friendly Version
View More

Upcoming Events

DateTitle
07/31/19
8:30 a.m. ET
Q2 2019 Charles River Laboratories International, Inc. Earnings Conference Call
View More

Stock Quote

CRL (common)
Price
$135.20
Change (%)
- 0.92 (0.68%)
Volume
174,358
Exchange
NYSE
Data as of 07/16/19 4:00 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)